Zai Lab acquired greater China rights to an argenx SE novel treatment for autoimmune indications in a deal worth up to $175 million in upfront and near-term payments. Ocumension Therapeutics invested ... ( read original story ...)
Chinese investors flood Hong Kong’s bruised stock market with cash
Chinese money is pouring into Hong Kong’s beaten-down stock market, highlighting the growing sway of mainland traders as political turmoil threatens to undermine the city’s status as a global finance ... ( read original story ...)
China Stock Index Heads Toward Record in Best Ever Start to Year
The priciest equities in more than five years are proving no deterrent for stock traders in China, where the benchmark is now nearing its all-time high. ( read original story ...)
Kweichow Moutai surpasses Shenzhen economy as meteoric rise sparks bubble concerns in China’s stock market
The liquor distiller surpassed lender ICBC by market value in 2020 and should become more than valuable than Shenzhen’s economy in 2021, based on some of the bullish targets among analysts covering ... ( read original story ...)
Asian stocks mixed as markets watch for Biden stimulus plan
Asian stocks are mixed as investors watch for details of President-elect Joe Biden's proposed economic stimulus plan ... ( read original story ...)
REFILE-UBS aims to double China investment banking staff for growth
UBS Group AG aims to double staff at its China investment banking business in 3-5 years, seeking to capture growth opportunities unleashed by Beijing's capital market reforms, a senior executive said ... ( read original story ...)
UBS aims to double China investment banking staff for growth
UBS Group AG aims to double staff at its China investment banking business in 3-5 years, seeking to capture growth opportunities unleashed by Beijing's capital market reforms, a senior executive said ... ( read original story ...)